Rheumatology clinical trials
High-volume rheumatology practices with infusion capability, deep autoimmune panels, and investigators holding prior trial experience across RA, gout, lupus, and systemic sclerosis. Patients on long-term therapy visit constantly, which is exactly why enrollment here runs fast.
Request rheumatology feasibilityWhat rheumatology capabilities do the sites have?
- 5,000 to 10,000+ active patients per site, tagged by indication and biologic experience.
- In-practice infusion rooms with experienced staff, supporting IV biologic protocols end to end.
- Ultrasound-guided injections, autoimmune nervous system testing, and cold laser therapy.
- Access-controlled IP room, -20 and -70 freezers, centrifuge and incubator.
- EKG, blood pressure, scales, and on-site lab area; dedicated exam and waiting space for research visits.
- Embedded medical monitor for the eligibility and safety judgment calls autoimmune protocols generate.
Where are the sites?
What rheumatology work is running now?
Active and upcoming work spans rheumatoid arthritis, gout, psoriatic arthritis, and lupus, including complex randomization-stage studies. Sponsor names and study identifiers stay confidential; for specifics against your protocol, send a synopsis and get an answer in 48 business hours, built the way we describe in how we build an enrollment number.
Frequently Asked Questions (FAQs)
Which rheumatology indications can Stryde sites support?
Rheumatoid arthritis, gout, psoriatic arthritis, lupus, Sjogren's, and systemic sclerosis, with investigators who hold prior PI and sub-investigator experience in these indications.
Do the sites support infusion-based protocols?
Yes. Rheumatology sites operate in-practice infusion rooms with experienced infusion staff, plus access-controlled IP storage and -20/-70 freezers for biologic protocols.
What specialized assessments are available?
Ultrasound-guided injections, autoimmune nervous system testing, cold laser therapy, EKG, and on-site lab processing, alongside standard safety assessments.
How large are the patient panels?
5,000 to 10,000+ active patients per site, tagged by indication and therapy status (biologic-experienced vs naive), which is what protocols actually filter on.
Planning a rheumatology protocol?
Preliminary feasibility from tagged patient counts in 48 business hours, or an honest answer within 4 hours on why it needs longer.